Amersham looks to diagnostics with Motorola deal:
This article was originally published in Clinica
UK company Amersham has bought Motorola Life Science's CodeLink pre-arrayed slides business in a $20m deal. The high-growth, $500m microarray market is mainly focused on the study of gene expression, but there is a significant opportunity to expand this into applications for clinical diagnostics, Amersham believes. The acquisition also builds on Amersham Biosciences' position in the self-spotted array market.